{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:36:10Z","timestamp":1788806170547,"version":"build-2803163510"},"reference-count":86,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/ijmm.2017.2952","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T13:48:21Z","timestamp":1492523301000},"page":"1357-1370","source":"Crossref","is-referenced-by-count":38,"title":["Proteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy"],"prefix":"10.3892","volume":"39","author":[{"given":"Sandra","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Zweyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Meleady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rustam R.","family":"Mundegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Swandulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Ohlendieck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,4,18]]},"reference":[{"key":"key20180107235135_b1-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"671viii","DOI":"10.1016\/j.ncl.2014.05.002","article-title":"Duchenne and Becker muscular dystrophies","volume":"32","author":"Flanigan","year":"2014","journal-title":"Neurol Clin"},{"key":"key20180107235135_b2-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"key20180107235135_b3-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","article-title":"The pathogenesis and therapy of muscular dystrophies","volume":"16","author":"Guiraud","year":"2015","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"key20180107235135_b4-ijmm-39-06-1357","first-page":"1","article-title":"Towards an understanding of the dystrophin-glycoprotein complex: Linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers","volume":"69","author":"Ohlendieck","year":"1996","journal-title":"Eur J Cell Biol"},{"key":"key20180107235135_b5-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-1-4419-6366-6_17","article-title":"Stretch-induced membrane damage in muscle: Comparison of wild-type and mdx mice","volume":"682","author":"Allen","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"key20180107235135_b6-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00007.2015","article-title":"Absence of dystrophin disrupts skeletal muscle signaling: Roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy","volume":"96","author":"Allen","year":"2016","journal-title":"Physiol Rev"},{"key":"key20180107235135_b7-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/978-1-4020-6191-2_16","article-title":"Calcium misregulation and the pathogenesis of muscular dystrophy","volume":"45","author":"Hopf","year":"2007","journal-title":"Subcell Biochem"},{"key":"key20180107235135_b8-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.biocel.2013.05.001","article-title":"Wasting mechanisms in muscular dystrophy","volume":"45","author":"Shin","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107235135_b9-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"C33","DOI":"10.1152\/ajpcell.00267.2013","article-title":"The role of proteases in excitation-contraction coupling failure in muscular dystrophy","volume":"308","author":"M\u00e1zala","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"key20180107235135_b10-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/pmic.201500158","article-title":"Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis","volume":"16","author":"Holland","year":"2016","journal-title":"Proteomics"},{"key":"key20180107235135_b11-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/mus.23432","article-title":"Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs","volume":"46","author":"Serra","year":"2012","journal-title":"Muscle Nerve"},{"key":"key20180107235135_b12-ijmm-39-06-1357","article-title":"Cytokines and chemokines as regulators of skeletal muscle inflammation: Presenting the case of Duchenne muscular dystrophy","volume":"540370","author":"De Paepe","year":"2013","journal-title":"Mediators Inflamm"},{"key":"key20180107235135_b13-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.15252\/emmm.201403967","article-title":"Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2","volume":"6","author":"Mojumdar","year":"2014","journal-title":"EMBO Mol Med"},{"key":"key20180107235135_b14-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"e1010966","DOI":"10.1080\/21675511.2015.1010966","article-title":"The immune system in Duchenne muscular dystrophy: Friend or foe","volume":"3","author":"Villalta","year":"2015","journal-title":"Rare Dis"},{"key":"key20180107235135_b15-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/cphy.c100092","article-title":"Mechanisms of muscle injury, repair, and regeneration","volume":"1","author":"Tidball","year":"2011","journal-title":"Compr Physiol"},{"key":"key20180107235135_b16-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci Transl Med"},{"key":"key20180107235135_b17-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"258ra142","DOI":"10.1126\/scitranslmed.3009925","article-title":"Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy","volume":"6","author":"Villalta","year":"2014","journal-title":"Sci Transl Med"},{"key":"key20180107235135_b18-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.jpeds.2013.06.015","article-title":"50 years ago in the Journal of Pediatrics: The use of serum creatine phosphokinase and other serum enzymes in the diagnosis of progressive muscular dystrophy","volume":"163","author":"Proud","year":"2013","journal-title":"J Pediatr"},{"key":"key20180107235135_b19-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajmg.1320130107","article-title":"Duchenne muscular dystrophy carrier detection using logistic discrimination: Serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination","volume":"13","author":"Percy","year":"1982","journal-title":"Am J Med Genet"},{"key":"key20180107235135_b20-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0009-8981(83)90405-9","article-title":"Carbonic anhydrase III in Duchenne muscular dystrophy","volume":"133","author":"Carter","year":"1983","journal-title":"Clin Chim Acta"},{"key":"key20180107235135_b21-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/0304-4165(86)90303-X","article-title":"Muscle adenylate kinase in Duchenne muscular dystrophy","volume":"883","author":"Fr\u00f6hlich","year":"1986","journal-title":"Biochim Biophys Acta"},{"key":"key20180107235135_b22-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/mus.880020503","article-title":"Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection","volume":"2","author":"Percy","year":"1979","journal-title":"Muscle Nerve"},{"key":"key20180107235135_b23-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ana.410350320","article-title":"Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy","volume":"35","author":"D'Amore","year":"1994","journal-title":"Ann Neurol"},{"key":"key20180107235135_b24-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI118101","article-title":"Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine","volume":"96","author":"Bernasconi","year":"1995","journal-title":"J Clin Invest"},{"key":"key20180107235135_b25-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2010.06.031","article-title":"Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy","volume":"297","author":"Sun","year":"2010","journal-title":"J Neurol Sci"},{"key":"key20180107235135_b26-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nmd.2011.05.011","article-title":"Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)","volume":"21","author":"Nadarajah","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"key20180107235135_b27-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/13892037113146660083","article-title":"Proteomics of the dystrophin-glycoprotein complex and dystrophinopathy","volume":"14","author":"Holland","year":"2013","journal-title":"Curr Protein Pept Sci"},{"key":"key20180107235135_b28-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/14789450.2016.1202768","article-title":"Understanding the molecular consequences of inherited muscular dystrophies: Advancements through proteomic experimentation","volume":"13","author":"Fuller","year":"2016","journal-title":"Expert Rev Proteomics"},{"key":"key20180107235135_b29-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12014-016-9109-x","article-title":"Clinical utility of serum biomarkers in Duchenne muscular dystrophy","volume":"13","author":"Hathout","year":"2016","journal-title":"Clin Proteomics"},{"key":"key20180107235135_b30-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/pmic.200700857","article-title":"Serum protein profiling in mice: Identification of Factor XIIIa as a potential biomarker for muscular dystrophy","volume":"8","author":"Alagaratnam","year":"2008","journal-title":"Proteomics"},{"key":"key20180107235135_b31-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00018-012-1248-2","article-title":"Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion","volume":"70","author":"Duguez","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"key20180107235135_b32-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1093\/hmg\/ddu366","article-title":"Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients","volume":"23","author":"Hathout","year":"2014","journal-title":"Hum Mol Genet"},{"key":"key20180107235135_b33-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/prca.201300072","article-title":"Fibronectin is a serum biomarker for Duchenne muscular dystrophy","volume":"8","author":"Cynthia Martin","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"key20180107235135_b34-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"918","DOI":"10.15252\/emmm.201303724","article-title":"Affinity proteomics within rare diseases: A BIO-NMD study for blood biomarkers of muscular dystrophies","volume":"6","author":"Ayoglu","year":"2014","journal-title":"EMBO Mol Med"},{"key":"key20180107235135_b35-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nmd.2014.03.012","article-title":"Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy","volume":"24","author":"Rouillon","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"key20180107235135_b36-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"17014","DOI":"10.1038\/srep17014","article-title":"Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics","volume":"5","author":"Coenen-Stass","year":"2015","journal-title":"Sci Rep"},{"key":"key20180107235135_b37-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1093\/hmg\/ddv214","article-title":"Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies","volume":"24","author":"Rouillon","year":"2015","journal-title":"Hum Mol Genet"},{"key":"key20180107235135_b38-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1073\/pnas.1507719112","article-title":"Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy","volume":"112","author":"Hathout","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107235135_b39-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/prca.201500044","article-title":"Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients","volume":"10","author":"Oonk","year":"2016","journal-title":"Proteomics Clin Appl"},{"key":"key20180107235135_b40-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/hmg\/5.8.1149","article-title":"Differential expression of dystrophin isoforms in strains of mdx mice with different mutations","volume":"5","author":"Im","year":"1996","journal-title":"Hum Mol Genet"},{"key":"key20180107235135_b41-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1203\/00006450-199207000-00025","article-title":"The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy","volume":"32","author":"Danko","year":"1992","journal-title":"Pediatr Res"},{"key":"key20180107235135_b42-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jgm.1265","article-title":"By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping","volume":"11","author":"Mitrpant","year":"2009","journal-title":"J Gene Med"},{"key":"key20180107235135_b43-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1179\/135100001101536580","article-title":"Haptoglobin, an inflammation-inducible plasma protein","volume":"6","author":"Wang","year":"2001","journal-title":"Redox Rep"},{"key":"key20180107235135_b44-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1073\/pnas.86.4.1292","article-title":"Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice","volume":"86","author":"Chapman","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107235135_b45-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1111\/febs.12267","article-title":"The mdx mouse model as a surrogate for Duchenne muscular dystrophy","volume":"280","author":"Partridge","year":"2013","journal-title":"FEBS J"},{"key":"key20180107235135_b46-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ab.2013.08.004","article-title":"Comparative proteomic analysis of the contractile-protein-depleted fraction from normal versus dystrophic skeletal muscle","volume":"446","author":"Carberry","year":"2014","journal-title":"Anal Biochem"},{"key":"key20180107235135_b47-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jprot.2009.07.001","article-title":"The dynamic range problem in the analysis of the plasma proteome","volume":"73","author":"Hortin","year":"2010","journal-title":"J Proteomics"},{"key":"key20180107235135_b48-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome: History, character, and diagnostic prospects","volume":"1","author":"Anderson","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"key20180107235135_b49-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"key20180107235135_b50-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"11317","DOI":"10.3390\/molecules200611317","article-title":"Comparative label-free mass spectrometric analysis of mildly versus severely affected mdx mouse skeletal muscles identifies annexin, lamin, and vimentin as universal dystrophic markers","volume":"20","author":"Holland","year":"2015","journal-title":"Molecules"},{"key":"key20180107235135_b51-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/pmic.201400471","article-title":"Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis","volume":"15","author":"Holland","year":"2015","journal-title":"Proteomics"},{"key":"key20180107235135_b52-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/proteomes3030298","article-title":"Concurrent label-free mass spectrometric analysis of dystrophin isoform Dp427 and the myofibrosis marker collagen in crude extracts from mdx-4cv skeletal muscles","volume":"3","author":"Murphy","year":"2015","journal-title":"Proteomes"},{"key":"key20180107235135_b53-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40199-015-0120-y","article-title":"Label-free LC-MS analysis of HER2+ breast cancer cell line response to HER2 inhibitor treatment","volume":"23","author":"Di Luca","year":"2015","journal-title":"Daru"},{"key":"key20180107235135_b54-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1021\/pr4012156","article-title":"Identification and functional validation of RAD23B as a potential protein in human breast cancer progression","volume":"13","author":"Linge","year":"2014","journal-title":"J Proteome Res"},{"key":"key20180107235135_b55-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jprot.2016.03.011","article-title":"Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy","volume":"145","author":"Murphy","year":"2016","journal-title":"J Proteomics"},{"issue":"D1","key":"key20180107235135_b56-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"D377","DOI":"10.1093\/nar\/gks1118","article-title":"PANTHER in 2013: Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees","volume":"41","author":"Mi","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"key20180107235135_b57-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3892\/ijmm.2012.1056","article-title":"Mass spectrometry-based proteomic analysis of middle-aged vs. aged vastus lateralis reveals increased levels of carbonic anhydrase isoform 3 in senescent human skeletal muscle","volume":"30","author":"Staunton","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20180107235135_b58-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1002\/pmic.201200578","article-title":"Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin","volume":"13","author":"Holland","year":"2013","journal-title":"Proteomics"},{"key":"key20180107235135_b59-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"648501","DOI":"10.1155\/2010\/648501","article-title":"Proteomic profiling of the dystrophin-deficient MDX heart reveals drastically altered levels of key metabolic and contractile proteins","volume":"2010","author":"Lewis","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"key20180107235135_b60-ijmm-39-06-1357","first-page":"397","article-title":"Simultaneous pathoproteomic evaluation of the dystrophin-glycoprotein complex and secondary changes in the mdx-4cv mouse model of Duchenne muscular dystrophy","volume":"4","author":"Murphy","year":"2015","journal-title":"Biology (Basel)"},{"key":"key20180107235135_b61-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12014-015-9099-0","article-title":"Label-free mass spectrometric analysis reveals complex changes in the brain proteome from the mdx-4cv mouse model of Duchenne muscular dystrophy","volume":"12","author":"Murphy","year":"2015","journal-title":"Clin Proteomics"},{"key":"key20180107235135_b62-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JND-140011","article-title":"Mass spectrometry-based identification of muscle-associated and muscle-derived proteomic biomarkers of dystrophinopathies","volume":"1","author":"Dowling","year":"2014","journal-title":"J Neuromuscul Dis"},{"key":"key20180107235135_b63-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jprot.2016.04.002","article-title":"With or without you - Proteomics with or without major plasma\/serum proteins","volume":"140","author":"Gianazza","year":"2016","journal-title":"J Proteomics"},{"key":"key20180107235135_b64-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/pmic.200500358","article-title":"Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database","volume":"5","author":"Omenn","year":"2005","journal-title":"Proteomics"},{"key":"key20180107235135_b65-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1479-5876-7-60","article-title":"Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer","volume":"7","author":"Pietrowska","year":"2009","journal-title":"J Transl Med"},{"key":"key20180107235135_b66-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/pmic.201100005","article-title":"A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses","volume":"11","author":"Smith","year":"2011","journal-title":"Proteomics"},{"key":"key20180107235135_b67-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1186\/1471-2164-15-904","article-title":"Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone disease","volume":"15","author":"Dowling","year":"2014","journal-title":"BMC Genomics"},{"key":"key20180107235135_b68-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jprot.2016.05.010","article-title":"A cost-effective method to get insight into the peritoneal dialysate effluent proteome","volume":"145","author":"Ara\u00fajo","year":"2016","journal-title":"J Proteomics"},{"key":"key20180107235135_b69-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/prca.200600276","article-title":"Investigation of an albumin-enriched fraction of human serum and its albuminome","volume":"1","author":"Gundry","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"key20180107235135_b70-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/pmic.200800686","article-title":"Assessment of albumin removal from an immunoaffinity spin column: Critical implications for proteomic examination of the albuminome and albumin-depleted samples","volume":"9","author":"Gundry","year":"2009","journal-title":"Proteomics"},{"key":"key20180107235135_b71-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1074\/mcp.M300031-MCP200","article-title":"Characterization of the low molecular weight human serum proteome","volume":"2","author":"Tirumalai","year":"2003","journal-title":"Mol Cell Proteomics"},{"key":"key20180107235135_b72-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1074\/mcp.M112.023127","article-title":"Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse","volume":"12","author":"Rayavarapu","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"key20180107235135_b73-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1093\/hmg\/ddv381","article-title":"Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration","volume":"24","author":"Roberts","year":"2015","journal-title":"Hum Mol Genet"},{"key":"key20180107235135_b74-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1074\/mcp.M116.059188","article-title":"Molecular signatures of membrane protein complexes underlying muscular dystrophy","volume":"15","author":"Turk","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"key20180107235135_b75-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/prca.201600028","article-title":"Acute phase proteins as promising biomarkers: Perspectives and limitations for human and veterinary medicine","volume":"10","author":"Schr\u00f6dl","year":"2016","journal-title":"Proteomics Clin Appl"},{"key":"key20180107235135_b76-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2217\/bmm.12.96","article-title":"Proteomic identification of biomarkers of skeletal muscle disorders","volume":"7","author":"Ohlendieck","year":"2013","journal-title":"Biomarkers Med"},{"key":"key20180107235135_b77-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/ars.2009.2793","article-title":"Haptoglobin: Basic and clinical aspects","volume":"12","author":"Levy","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"key20180107235135_b78-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/elps.1150100707","article-title":"Elevated plasma levels of haptoglobin in Duchenne muscular dystrophy: Electrophoretic variants in patients with a severe form of the disease","volume":"10","author":"John","year":"1989","journal-title":"Electrophoresis"},{"key":"key20180107235135_b79-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"e1153777","DOI":"10.1080\/21675511.2016.1153777","article-title":"Dystrophin: The dead calm of a dogma","volume":"4","author":"G\u00f3recki","year":"2016","journal-title":"Rare Dis"},{"key":"key20180107235135_b80-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"491497","DOI":"10.1155\/2013\/491497","article-title":"Macrophage plasticity and the role of inflammation in skeletal muscle repair","volume":"2013","author":"Kharraz","year":"2013","journal-title":"Mediators Inflamm"},{"key":"key20180107235135_b81-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"e1001888","DOI":"10.1371\/journal.pmed.1001888","article-title":"2R X7 purinoceptor: A therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy","volume":"12","author":"Sinadinos","year":"2015","journal-title":"PLoS Med"},{"key":"key20180107235135_b82-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1074\/mcp.M500006-MCP200","article-title":"Biomarkers: Mining the biofluid proteome","volume":"4","author":"Veenstra","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"key20180107235135_b83-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.3390\/ijms131113926","article-title":"The proteomics big challenge for biomarkers and new drug-targets discovery","volume":"13","author":"Savino","year":"2012","journal-title":"Int J Mol Sci"},{"key":"key20180107235135_b84-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/pmic.201100346","article-title":"Secreted proteins as a fundamental source for biomarker discovery","volume":"12","author":"Stastna","year":"2012","journal-title":"Proteomics"},{"key":"key20180107235135_b85-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1878-5085-4-7","article-title":"Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine","volume":"4","author":"Drucker","year":"2013","journal-title":"EPMA J"},{"key":"key20180107235135_b86-ijmm-39-06-1357","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1002\/ijc.29993","article-title":"Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis","volume":"138","author":"Sun","year":"2016","journal-title":"Int J Cancer"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2017.2952\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T15:59:44Z","timestamp":1658937584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2017.2952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,18]]},"references-count":86,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,4,18]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/ijmm.2017.2952"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2017.2952","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,18]]}}}